NCT00752726View on ClinicalTrials.gov

Effect of Orlistat in Body Composition

PHASE4CompletedINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
ObesityOverweight
Interventions
DRUG

Orlistat

Weight loss treatment

DRUG

Placebo

Inactive

Trial Locations (3)

27710

Duke Clinical Research Unit, Durham

70808

Pennington Biomedical Research Center, Baton Rouge

405 30

Sahlgrenska Academy, Gothenburg

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00752726 - Effect of Orlistat in Body Composition | Biotech Hunter | Biotech Hunter